(Q50497862)

14 March 2018

title

Cisplatin-induced hearing loss: influence of the mode of drug administration in the guinea pig. (English)

1 reference

14 March 2018

1 reference

Ekborn A

1

1 reference

14 March 2018

Laurell G

2

1 reference

14 March 2018

Andersson A

3

1 reference

14 March 2018

Wallin I

4

1 reference

14 March 2018

Eksborg S

5

1 reference

14 March 2018

Ehrsson H

6

1 reference

14 March 2018

publication date

1 February 2000

1 reference

14 March 2018

published in

Hearing Research

1 reference

14 March 2018

volume

140

1 reference

14 March 2018

issue

1-2

1 reference

14 March 2018

page(s)

38-44

1 reference

14 March 2018

Some procedures to reduce cis-platinum toxicity reduce antitumour activity

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900190-2

7 January 2021

Determination of cisplatin and cis-diammineaquachloroplatinum(II) ion by liquid chromatography using post-column derivatization with diethyldithiocarbamate

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900190-2

7 January 2021

Pharmacokinetics of cisplatin and its monohydrated complex in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900190-2

7 January 2021

Monitoring of hearing during treatment of leukaemia with special reference to the use of amikacin.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900190-2

7 January 2021

Modification of cisplatin toxicity with diethyldithiocarbamate

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900190-2

7 January 2021

Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900190-2

7 January 2021

Statistical estimations in pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900190-2

7 January 2021

Cisplatin nephrotoxicity: a summary of preventative interventions.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900190-2

7 January 2021

Ototoxicity of cis-dichlorodiammine platinum (II) in the guinea pig

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900190-2

7 January 2021

Cisplatin rescue therapy: experience with sodium thiosulfate, WR2721, and diethyldithiocarbamate

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900190-2

7 January 2021

Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900190-2

7 January 2021

High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900190-2

7 January 2021

The relative nephrotoxicity of cisplatin,cis-[Pt(NH3)2(guanosine)2]2+, and the hydrolysis product of cisplatin in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900190-2

7 January 2021

The ototoxic effect of cisplatin on guinea pigs in relation to dosage

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900190-2

7 January 2021

Distribution of cisplatin in perilymph and cerebrospinal fluid after intravenous administration in the guinea pig

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900190-2

7 January 2021

Testicular cancer and the legacy of chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900190-2

7 January 2021

Quantitative relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity in rats: importance of area under the concentration-time curve (AUC) as the major toxicodynamic determinant in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900190-2

7 January 2021

Influence of infusion time on unchanged cisplatin disposition in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900190-2

7 January 2021

Mechanism of Protection by Diethyldithiocarbamate against Cisplatin Ototoxicity: Antioxidant System

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900190-2

7 January 2021

Cis-diamminedichloroplatinum (II) by 5-day continuous infusion. A new dose schedule with minimal toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900190-2

7 January 2021

Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900190-2

7 January 2021

Ototoxicity of cis-diamminedichloroplatinum (II): influence of dose, schedule and mode of administration

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900190-2

7 January 2021

The kinetics and cytotoxicity of cisplatin and its monohydrated complex

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900190-2

7 January 2021

Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900190-2

7 January 2021

10.1016/S0378-5955(99)00190-2

Identifiers

DOI

1 reference

14 March 2018

1 reference

14 March 2018